The cancer disappeared, the researchers injected it again – and then came the surprise
A new study by Regeneron succeeded in eliminating cancerous tumors in all nine mice tested, using a combination of an existing drug and an experimental antibody. After treatment ended, the mice's immune system recognized newly injected cancer cells and prevented tumor development without additional drugs.
A new study published in Nature Communications presents encouraging results in mice: a combination of the existing drug Enhertu with an experimental antibody succeeded in eliminating cancerous tumors in all nine mice tested. The big surprise came several weeks later, when researchers injected the mice again with cancer cells – and their immune system recognized them and prevented tumor development without further treatment. The researchers found that the treatment created a targeted immune memory against the original tumor, but not against other types of cancer. The study was funded by Regeneron, and all its authors are its employees. The experimental antibody is in early stages of clinical trials in humans, but the method's efficacy or safety in humans has not yet been proven.
The cancer disappeared, the researchers injected it again – and then came the surprise